Archive: 22/05/2018

CD93 protein suggests new strategy to inhibit cancer

One strategy for cancer therapy is to inhibit the development of blood vessels in the tumour. Researchers at Uppsala University show in a new study how the protein CD93 interacts with the protein network that is required ...

Physiology-stratified analysis of ORBITA

Invasive physiology data from 196 patients from the Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina (ORBITA) trial were used to assess the fractional flow reserve (FFR) ...

page 7 from 10